Dmitry Karshtedt

Dmitry Karshtedt
Title:
Associate Professor of Law
Address:
2000 H Street, NW
Washington, District Of Columbia 20052
Phone:
202-994-5725
Email:
[email protected]

Dmitry Karshtedt's primary research interest is in patent law. His legal scholarship has been or will be published in the Vanderbilt Law Review, Washington University Law Review, and Iowa Law Review, and cited in three of the leading patent law casebooks and a casebook on intellectual property. Professor Karshtedt's academic work has won several awards, including the Samsung-Stanford Patent Prize and the scholarship grant for judicial clerks sponsored by the University of Houston Law Center Institute for Intellectual Property and Information Law.

Before going into law, Professor Karshtedt completed a Ph.D. in chemistry from U.C. Berkeley and worked as a staff scientist for a semiconductor materials startup. He is a co-author on five scientific publications and a co-inventor on ten U.S. patents. Professor Karshtedt received his law degree from Stanford Law School, where he served as the Senior Symposium Editor for the Stanford Law Review. Professor Karshtedt practiced in the Patent Counseling and Innovation Group at Wilson Sonsini Goodrich & Rosati and clerked for the Honorable Kimberly A. Moore on the U.S. Court of Appeals for the Federal Circuit. Immediately prior to starting his position at GW, Professor Karshtedt was a Fellow at the Center for Law and the Biosciences at Stanford Law School.

Curriculum Vitae     Publications

Education

AB, Harvard University; Ph.D., U.C. Berkeley; JD, Stanford University

In the News

"All You Need to Know for Round 2 of the CRISPR Patent Fight"

April 27, 2018

Dmitry Karshtedt is quoted in Stat News about the "important, high-profile case" over CRISPR patents.

"Oil States: Engaging with History, Private Property, and the Privy Council"

November 27, 2017

Dmitry Karshtedt writes in Patently-O about the Supreme Court case, Oil States v. Greene's Energy.

"Allergan Has Made an Unorthodox Agreement with an American Indian Tribe to Fend Off Competition for Its Key Product"

September 08, 2017

Dmitry Karshtedt is quoted in MarketWatch regarding the patents on a key Allergan product, the dry eye medication Restasis.

Brief of Professor Dmitry Karshtedt as Amicus Curiae Supporting Petitioner

August 31, 2017

Dmitry Karshtedt filed an amicus brief in a patent case at the Supreme Court.